Department of Environmental Health Sciences, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
Division of Environmental Medicine, Grossman School of Medicine, New York University, New York, NY, USA.
Part Fibre Toxicol. 2024 Oct 8;21(1):42. doi: 10.1186/s12989-024-00594-6.
Subway systems are becoming increasingly common worldwide transporting large populations in major cities. PM concentrations have been demonstrated to be exceptionally high when underground, however. Studies on the impact of subway PM exposure on cardiopulmonary health in the United States are limited.
Healthy volunteers in New York City were exposed to a 2-h visit on the 9th Street Station platform on the Port Authority Trans-Hudson train system. Blood pressure, heart rate variability (HRV), spirometry, and forced impulse oscillometry were measured, and urine, blood spot, and nasal swab biosamples were collected for cytokine analysis at the end of the 2-h exposure period. These endpoints were compared against individual control measurements collected after 2-h in a "clean" control space. In addition to paired comparisons, mixed effects models with subject as a random effect were employed to investigate the effect of the PM concentrations and visit type (i.e., subway vs. control).
Mean PM concentrations on the platform and during the control visit were 293.6 ± 65.7 (SD) and 4.6 ± 1.9 µg/m, respectively. There was no change in any of the health metrics, but there was a non-significant trend for SDNN to be lower after subway exposure compared to control exposure. Total symptomatic scores did increase post-subway exposure compared to reported values prior to exposure or after the control visit. No significant changes in cytokine concentrations in any specimen type were observed. Mixed-effects models mostly corroborated these paired comparisons.
Acute exposures to PM on a subway platform do not cause measurable cardiopulmonary effects apart from reductions in HRV and increases in symptoms in healthy volunteers. These findings match other studies that found little to no changes in lung function and blood pressure after exposure in underground subway stations. Future work should still target potentially more vulnerable populations, such as individuals with asthma or those who spend increased time underground on the subway such as transit workers.
地铁系统在全球范围内越来越普遍,可在主要城市中运送大量人群。然而,当处于地下时,地铁中的 PM 浓度会异常高。在美国,有关地铁 PM 暴露对心肺健康影响的研究有限。
在纽约市,健康志愿者在港务局过境哈德逊火车系统的第 9 街站平台上接受了 2 小时的暴露。在 2 小时暴露期结束时,测量血压、心率变异性(HRV)、肺活量测定法和强迫脉冲振荡法,并采集尿液、血斑和鼻腔拭子生物样本,用于细胞因子分析。这些终点与在“清洁”对照空间中 2 小时后采集的个体对照测量值进行比较。除了配对比较之外,还采用混合效应模型,将受试者作为随机效应,以研究 PM 浓度和访问类型(即地铁与对照)的影响。
平台上和对照访问期间的平均 PM 浓度分别为 293.6±65.7(SD)和 4.6±1.9μg/m。除了 SDNN 在地铁暴露后比对照暴露后更低的趋势外,没有任何健康指标发生变化。与暴露前或对照访问后的报告值相比,地铁暴露后总症状评分确实增加。在任何标本类型中均未观察到细胞因子浓度的显著变化。混合效应模型大多证实了这些配对比较。
除了降低 HRV 和增加健康志愿者的症状外,地铁平台上的 PM 急性暴露不会引起可测量的心肺影响。这些发现与其他研究结果一致,即在地下地铁站暴露后,肺功能和血压几乎没有变化。未来的工作仍应针对潜在的更脆弱人群,例如哮喘患者或在地铁上花费更多时间的人,例如过境工人。